share_log

Returns On Capital Are Showing Encouraging Signs At Insulet (NASDAQ:PODD)

Returns On Capital Are Showing Encouraging Signs At Insulet (NASDAQ:PODD)

Insulet(納斯達克股票代碼:PODD)的資本回報率顯示出令人鼓舞的跡象
Simply Wall St ·  05/22 21:46

What are the early trends we should look for to identify a stock that could multiply in value over the long term? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. So when we looked at Insulet (NASDAQ:PODD) and its trend of ROCE, we really liked what we saw.

我們應該尋找哪些早期趨勢來確定一隻可能長期價值成倍增長的股票?理想情況下,企業將表現出兩種趨勢;首先是增長 返回 論資本使用率(ROCE),其次是增加 金額 所用資本的比例。簡而言之,這些類型的企業是複合機器,這意味着他們不斷以更高的回報率對收益進行再投資。因此,當我們研究Insulet(納斯達克股票代碼:PODD)及其投資回報率趨勢時,我們真的很喜歡我們所看到的。

What Is Return On Capital Employed (ROCE)?

什麼是資本使用回報率(ROCE)?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. The formula for this calculation on Insulet is:

爲了澄清一下你是否不確定,ROCE是評估公司從投資於其業務的資本中獲得多少稅前收入(按百分比計算)的指標。在 Insulet 上進行此計算的公式爲:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

已動用資本回報率 = 息稅前收益 (EBIT) ¥(總資產-流動負債)

0.12 = US$265m ÷ (US$2.6b - US$432m) (Based on the trailing twelve months to March 2024).

0.12 = 2.65億美元 ÷(26億美元-4.32億美元) (基於截至2024年3月的過去十二個月).

Thus, Insulet has an ROCE of 12%. In absolute terms, that's a pretty normal return, and it's somewhat close to the Medical Equipment industry average of 10%.

因此,Insulet的投資回報率爲12%。從絕對值來看,這是一個相當正常的回報,略接近醫療設備行業10%的平均水平。

roce
NasdaqGS:PODD Return on Capital Employed May 22nd 2024
NASDAQGS: PODD 2024年5月22日動用資本回報率

Above you can see how the current ROCE for Insulet compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like, you can check out the forecasts from the analysts covering Insulet for free.

上面你可以看到Insulet當前的投資回報率與其先前的資本回報率相比如何,但從過去可以看出來的只有那麼多。如果你願意,你可以免費查看報道Insulet的分析師的預測。

The Trend Of ROCE

ROCE 的趨勢

The trends we've noticed at Insulet are quite reassuring. The data shows that returns on capital have increased substantially over the last five years to 12%. Basically the business is earning more per dollar of capital invested and in addition to that, 161% more capital is being employed now too. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed.

我們在Insulet注意到的趨勢非常令人放心。數據顯示,在過去五年中,資本回報率大幅上升至12%。基本上,企業每投資1美元的資本就能獲得更多的收入,除此之外,現在使用的資本也增加了161%。越來越多的資本所帶來的回報率不斷增加在多袋公司中很常見,這就是爲什麼我們印象深刻的原因。

What We Can Learn From Insulet's ROCE

我們可以從Insulet的投資回報率中學到什麼

All in all, it's terrific to see that Insulet is reaping the rewards from prior investments and is growing its capital base. And with a respectable 67% awarded to those who held the stock over the last five years, you could argue that these developments are starting to get the attention they deserve. So given the stock has proven it has promising trends, it's worth researching the company further to see if these trends are likely to persist.

總而言之,看到Insulet從先前的投資中獲得回報並不斷擴大其資本基礎真是太棒了。而且,在過去五年中持有該股票的人將獲得可觀的67%的獎勵,你可以說這些發展已開始得到應有的關注。因此,鑑於該股已證明其趨勢令人鼓舞,值得進一步研究該公司,看看這些趨勢是否可能持續下去。

One more thing to note, we've identified 1 warning sign with Insulet and understanding it should be part of your investment process.

還有一件事需要注意,我們已經確定了Insulet的1個警告信號,並知道它應該成爲您投資過程的一部分。

While Insulet may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

儘管Insulet目前可能無法獲得最高的回報,但我們編制了一份目前股本回報率超過25%的公司名單。在這裏查看這個免費清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論